About Us
Reimagining How Drugs Are Discovered
Axia Discovery was founded on a simple premise: the computational tools that transformed physics and engineering can do the same for drug discovery — if applied with scientific rigor.
Our Mission
Accelerate the path from target to treatment
Traditional drug discovery is slow, expensive, and prone to failure. 90% of clinical candidates never reach patients. We believe computational methods can dramatically improve these odds by identifying better candidates earlier in the process.
Our goal is to compress the preclinical timeline from years to months, reduce costs by orders of magnitude, and most importantly — help effective treatments reach patients who need them.
Our Values
Principles that guide our work
Scientific Rigor
Every computational prediction is validated against experimental benchmarks. We publish our methods and welcome scrutiny.
Speed Without Shortcuts
We accelerate discovery through smarter algorithms, not by cutting corners on validation or safety.
Transparency
Open communication with partners, clear reporting of results, and honest assessment of what our models can and cannot do.
Patient-Centered
Every target we pursue, every compound we optimize — we never lose sight of the patients waiting for better treatments.
Our Approach
How we do things differently
Physics-First Modeling
Our simulations are grounded in molecular dynamics and quantum mechanics, not just pattern matching. This gives us predictive power where pure ML approaches fail.
AI-Augmented Design
Deep learning accelerates our search through chemical space, but human expertise guides target selection and validates every candidate.
Peptide Specialization
We focus on peptide therapeutics — a modality perfectly suited to computational design due to their defined structure and predictable binding behavior.
Iterative Refinement
Our platform learns from every experiment. Failed predictions become training data, continuously improving our models.
Interested in partnering with us?
We're always looking for collaborators who share our vision for the future of drug discovery.
Get in Touch